Balancing Innovation and Affordability in Biopharmaceuticals: A Call for Sustainable Drug Pricing

Abstract

The biopharmaceutical industry has revolutionized healthcare with groundbreaking therapies such as gene therapies, immunotherapies, and precision medicine. These advances have brought new hope to patients with chronic and life-threatening diseases. However, the escalating costs of these therapies have created a critical challenge: balancing innovation with affordability. The rising prices of biopharmaceuticals limit access for millions globally, particularly in low- and middle-income countries, and strain healthcare systems, calling for a sustainable approach to drug pricing.